ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,145.29
1.39%
S&P 500
5,297.10
-0.21%
Dow Jones
39,869.38
-0.10%
US Dollar vs Yen
155.6385
0.16%
Brent Oil
83.545
0.41%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Enveric Biosciences Inc (ENVB)

  7. Enveric Biosciences Inc (ENVB) ニュース

ENVB

Enveric Biosciences (ENVB)

Enveric Biosciences Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ENVB
日付受信時刻ニュースソース見出しコード企業名
2024/05/1519 : 00Business WireEnveric Biosciences Reports First Quarter 2024 Financial and Corporate ResultsNASDAQ:ENVBEnveric Biosciences Inc
2024/05/1421 : 00Business WireEnveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health DisordersNASDAQ:ENVBEnveric Biosciences Inc
2024/05/0820 : 00Business WireEnveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using CannabinoidsNASDAQ:ENVBEnveric Biosciences Inc
2024/03/2620 : 00Business WireEnveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023NASDAQ:ENVBEnveric Biosciences Inc
2024/03/1920 : 00Business WireEnveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint DiseaseNASDAQ:ENVBEnveric Biosciences Inc
2024/03/1220 : 00Business WireEnveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term SheetsNASDAQ:ENVBEnveric Biosciences Inc
2024/03/1201 : 35Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ENVBEnveric Biosciences Inc
2024/03/1121 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
2024/02/2921 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
2024/02/2921 : 00Business WireEnveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of CompoundsNASDAQ:ENVBEnveric Biosciences Inc
2024/02/2706 : 53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENVBEnveric Biosciences Inc
2024/02/2706 : 47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENVBEnveric Biosciences Inc
2024/02/2706 : 42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENVBEnveric Biosciences Inc
2024/02/2322 : 00Business WireEnveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual PropertyNASDAQ:ENVBEnveric Biosciences Inc
2024/02/2122 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
2024/02/2122 : 00Business WireEnveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health DisordersNASDAQ:ENVBEnveric Biosciences Inc
2024/02/1505 : 36Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ENVBEnveric Biosciences Inc
2024/02/0922 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
2024/02/0700 : 17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ENVBEnveric Biosciences Inc
2024/02/0607 : 09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ENVBEnveric Biosciences Inc
2024/01/2422 : 05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ENVBEnveric Biosciences Inc
2024/01/2314 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ENVBEnveric Biosciences Inc
2024/01/1206 : 43Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ENVBEnveric Biosciences Inc
2024/01/0906 : 42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
2024/01/0322 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
2023/12/3006 : 43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
2023/12/2922 : 52Business WireEnveric Biosciences Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.8 Million Gross Proceeds Priced At-the-MarketNASDAQ:ENVBEnveric Biosciences Inc
2023/12/2822 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
2023/12/2822 : 00Business WireEnveric Biosciences Selects EB-003 as Lead Drug Candidate from EVM301 SeriesNASDAQ:ENVBEnveric Biosciences Inc
2023/12/2722 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENVBEnveric Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ENVB

最近閲覧した銘柄

LSE
MGZ7
TG
TKY
Tokyo Electron
LSE
0HVF
Centerpoint Energy
BIT
1ELX
Estee Lauder Companies
FX
EURBMD
Euro vs BMD
NASDAQ
RLLIX
LSE
103O
ASX
NGYN
LSE
HYWD
Heywood Williams
NASDAQ
ZCZZT
Test
BIT
UC6M17
Unicredit Bank
EU
IEXCH
Cours de lindice ISHARES...
BOV
Z1TS34Q
Zoetis
COIN
SPONGEUST
SpongeBob
BITMOT
889565
World Bank Zc Mg31 Rub
BIT
UB8C66
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有